AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI 12L--the AI powering the Kardia ...
AliveCor, Inc. v. Apple, Inc., No. 23-1512 (Fed. Cir. 2025) – On March 7, 2025, the Federal Circuit affirmed the Patent Trial and Appeal Board’s inter partes review (“IPR”) decisions invalidating all ...
San Francisco-based AliveCor announced that the FDA has granted its smartphone-enabled, single-channel ECG (electrocardiogram) recorder device over-the-counter (OTC) clearance. The company is now ...
On March 7, 2025, the Federal Circuit issued a decision resolving the ongoing patent litigation between AliveCor and Apple concerning methods of cardiac monitoring purportedly employed in certain of ...
AliveCor has launched (and received FDA clearance for) a new ECG sensor built into an Apple Watch strap, as well as an Apple Watch app on which users can see their ECG in near real-time. The strap, ...
Mobile health technology company AliveCor and remote monitoring company Preventice Solutions are piloting a mobile technology to analyze echocardiograms more efficiently. Preventice Solutions, a ...
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection, more insights, and ongoing access to board-certified cardiologist ECG reviews. KardiaAlert is a ...
MOUNTAIN VIEW, Calif., Dec. 5, 2024 /PRNewswire/ -- AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the company has been named 2024 Inc ...
Digital health startup AliveCor selected Vic Gundotra as CEO, according to mobihealthnews. AliveCor provides mobile echocardiogram apps and devices. Mr. Gundotra is taking over the CEO role from Euan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback